News
Why Viking Therapeutics Stock Was Victorious This Week
Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was a winning stock this week. Over the course of the past five trading days
Why Lockheed Martin Stock Popped, Then Dropped Today
Lockheed Martin (NYSE: LMT) is riding the market roller coaster on Friday.
In early trading, shares of the defense giant jumped nearly 3% on a Wells Fargo report calling the new fiscal year 2026
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
Positive jobs news and positive rumors out of China are lifting stock markets today, as the U.S. Labor Department reports adjusted nonfarm payrolls grew by 177,000 jobs in April, and CNBC reports
This Soaring Stock Just Delivered More Good News. Time to Buy?
It's hard to find a biotech company that has performed better than Summit Therapeutics (NASDAQ: SMMT) in the past year. The stock is up by a whopping 512%, and it's no secret why.
Summit, a
Members of Congress Are Buying These 4 Warren Buffett Stocks. Should You?
Bipartisan support for banning U.S. senators and representatives from buying and selling stocks while they're in office is picking up momentum. President Trump recently stated that he would
Where Will Viking Therapeutics Be in 3 Years?
The pharmaceutical and biotechnology business tends to be about hitting home runs more than just getting on base. A highly successful drug, sometimes referred to as a blockbuster, can build up a
EQS-News: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
Is AT&T Stock Going to $34? 1 Wall Street Analyst Thinks So.
AT&T (NYSE: T) stock has been a strong performer, surging 64% over the last year. But Tigress Financial analyst Ivan Feinseth sees more upside following AT&T's first-quarter earnings report.
The
Billionaire Ken Griffin Says Trump's Tariffs Have Made the U.S. "20% Poorer." Here's What You Can Do to Prevent Further Wealth Erosion.
Billionaire Ken Griffin is a major supporter of President Donald Trump and donated $100 million last year to conservative groups. However, Griffin isn't a fan of all the president's policies.
He
Should You Buy AMD Stock Before May 6?
In this video, I will cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.
*Stock
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with
Up Over 60% in the Past Year, Is It Too Late to Buy AT&T Stock?
AT&T (NYSE: T) is a leading telecom company in the country -- and as it has exited the streaming and media businesses and refocused on its core operations, it has been proving to be a solid
1 Beaten-Down Stock to Buy and Hold for 10 Years
Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent clinical progress. However, things have been very different in 2025
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
One great thing about a crash or downturn in the markets is that it can allow you to go bargain hunting fairly easily. Many stocks have been falling this year, and if you're a dividend investor, you
Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul
Entering trading on Monday, the S&P 500 has declined around 6% since the start of the year. And that's after recovering recently -- it was down much more than that in early April when global tariffs
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth treatment areas: and that's weight loss. Analysts forecast a compound annual
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
Why Viking Therapeutics Stock Popped Again Today
Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts.
Viking stock inched higher Monday after Truist Securities
If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today
Few would dispute that Pfizer (NYSE: PFE) is an icon within the pharmaceutical world. And, giving credit where it's due, the drugmaker largely led the charge against the COVID-19 pandemic with both
AT&T Stock Is Back to Multiyear Highs. Time to Buy?
AT&T (NYSE: T) stock appears to be benefiting from its most promising outlook in years. Earlier in the decade, the stock suffered after the company slashed its dividend in 2022 following 35
EQS-News: Evotec SE to announce results for the first quarter 2025 on 6 May 2025
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
Why AbbVie Stock Trounced the Market Today
The positive, post-earnings momentum lifting AbbVie's (NYSE: ABBV) stock price continued on Monday. The veteran healthcare company's shares booked a gain of more than 3% during the trading session
Why Viking Therapeutics Stock Popped Today
Viking Therapeutics (NASDAQ: VKTX) stock inched 2.3% higher through 10:20 a.m. ET Monday, and for a most curious reason.
Truist Securities analyst Joon Lee just lowered his price target on the